The phase IV clinical trial in China is making a rapid progress despite its late start and its research significance and importance have been recognized gradually. There exist many problems behind the rapid development, while these could be effectively managed and solved by the further definitude of free medicine in the phase IV clinical trial, selection of regulatory institutions, expansion of project scope, development of institutions and ethics committee functions and reinforcement of the IV clinical trial management.